Incyte (INCY) Interest Coverage Ratio: History & Chart

Incyte Corporation(INCY)

Biotechnology · Wilmington, DE

$125.31-2.31 (-1.81%)

Delayed quote: Sep 18, 2026, 4:00 PM EDT

About Incyte Corporation

Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. Beyond its marketed drugs, Incyte's pipeline features several promising candidates. Among its clinical-stage assets are ruxolitinib, targeting steroid-refractory chronic graft-versus-host disease (GVHD), and itacitinib, which is undergoing Phase II/III trials for newly diagnosed chronic GVHD. Pemigatinib is also being investigated for conditions such as bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and other tumor types. Further advancing its research, the company is developing Parsaclisib, currently in Phase II studies for follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma. Additionally, Retifanlimab is in Phase II development for multiple indications, including MSI-high endometrial cancer, Merkel cell carcinoma, anal cancer, and non-small cell lung cancer. Incyte maintains a broad network of strategic alliances with numerous pharmaceutical and biotech companies, including key partners like Novartis International Pharmaceutical Ltd., Eli Lilly and Company, and Agenus Inc., among many others. These collaborations extend to clinical trials, notably joint efforts with MorphoSys AG and Xencor, Inc., to evaluate a combination therapy involving tafasitamab, plamotamab, and lenalidomide for patients with recurrent or resistant diffuse large B-cell lymphoma and follicular lymphoma. Established in 1991, the corporation's main offices are situated in Wilmington, Delaware.

Wilmington, DE

2,844 employees

www.incyte.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: William J. Meury

View full financials

INCY Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

553.04x

INTEREST COVERAGE RATIO AVG TTM

736.49x

INTEREST COVERAGE RATIO AVG 3Y

499.70x

INTEREST COVERAGE RATIO AVG 5Y

357.50x

INTEREST COVERAGE RATIO AVG 10Y

232.34x

INTEREST COVERAGE RATIO AVG 15Y

131.89x

INTEREST COVERAGE RATIO AVG 20Y

96.59x

CURRENT VS TTM AVG

-24.91%

CURRENT VS 3Y AVG

+10.67%

CURRENT VS 5Y AVG

+54.70%

CURRENT VS 10Y AVG

+138.03%

CURRENT VS 15Y AVG

+319.33%

CURRENT VS 20Y AVG

+472.59%

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

+7932.53%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Incyte Corporation (INCY)	$25.40B	553.04x	736.49x	499.70x	357.50x
West Pharmaceutical Services, Inc. (WST)vs ›	$25.49B	1029.00x	617.01x	353.82x	258.97x
Labcorp Holdings Inc. (LH)vs ›	$26.30B	6.77x	5.99x	5.91x	8.30x
BioNTech SE (BNTX)vs ›	$24.13B	-45.74x	444.02x	1201.03x	1201.03x
Medline Inc. (MDLN)vs ›	$26.75B	2.72x	2.21x	1.60x	1.60x
Quest Diagnostics Incorporated (DGX)vs ›	$27.20B	5.79x	5.88x	7.29x	9.45x
Mettler-Toledo International Inc. (MTD)vs ›	$28.14B	16.32x	15.71x	16.43x	18.17x
GE HealthCare Technologies Inc. (GEHC)vs ›	$28.97B	6.14x	5.67x	11.29x	26.04x
United Therapeutics Corporation (UTHR)vs ›	$21.00B	77.81x	54.95x	40.03x	35.88x
Zoetis Inc. (ZTS)vs ›	$29.95B	14.80x	14.41x	13.27x	12.34x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Incyte Corporation (INCY)

$25.40B

553.04x

736.49x

499.70x

357.50x

West Pharmaceutical Services, Inc. (WST)vs ›

$25.49B

1029.00x

617.01x

353.82x

258.97x

Labcorp Holdings Inc. (LH)vs ›

$26.30B

6.77x

5.99x

5.91x

8.30x

BioNTech SE (BNTX)vs ›

$24.13B

-45.74x

444.02x

1201.03x

Medline Inc. (MDLN)vs ›

$26.75B

2.72x

2.21x

1.60x

Quest Diagnostics Incorporated (DGX)vs ›

$27.20B

5.79x

5.88x

7.29x

9.45x

Mettler-Toledo International Inc. (MTD)vs ›

$28.14B

16.32x

15.71x

16.43x

18.17x

GE HealthCare Technologies Inc. (GEHC)vs ›

$28.97B

6.14x

5.67x

11.29x

26.04x

United Therapeutics Corporation (UTHR)vs ›

$21.00B

77.81x

54.95x

40.03x

35.88x

Zoetis Inc. (ZTS)vs ›

$29.95B

14.80x

14.41x

13.27x

12.34x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Incyte Corporation (INCY)?

The interest coverage ratio for INCY stock is 553.04x.

Is Incyte Corporation's interest coverage ratio high or low?

The interest coverage ratio of 553.04x is 55% above its 5-year average of 357.50x, around the middle of its 5-year range (-727.75x–1201.20x).

What is the TTM average interest coverage ratio for Incyte Corporation (INCY)?

The TTM average interest coverage ratio for INCY stock is 736.49x.

What is the 3Y average interest coverage ratio for Incyte Corporation (INCY)?

The 3Y average interest coverage ratio for INCY stock is 499.70x.

What is the 5Y average interest coverage ratio for Incyte Corporation (INCY)?

The 5Y average interest coverage ratio for INCY stock is 357.50x.

What is the 10Y average interest coverage ratio for Incyte Corporation (INCY)?

The 10Y average interest coverage ratio for INCY stock is 232.34x.

What is the 15Y average interest coverage ratio for Incyte Corporation (INCY)?

The 15Y average interest coverage ratio for INCY stock is 131.89x.

What is the 20Y average interest coverage ratio for Incyte Corporation (INCY)?

The 20Y average interest coverage ratio for INCY stock is 96.59x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	1201.20x
2026-03-31	569.72x
2025-12-31	659.73x
2025-09-30	728.54x
2025-06-30	523.25x
2025-03-31	328.36x
2024-12-31	709.70x
2024-09-30	188.74x
2024-06-30	-727.75x
2024-03-31	213.72x
2023-12-31	232.92x
2023-09-30	344.63x
2023-06-30	295.85x
2023-03-31	52.81x
2022-12-31	105.09x
2022-09-30	215.88x
2022-06-30	375.27x
2022-03-31	171.38x
2021-12-31	147.25x
2021-09-30	536.24x
2021-06-30	393.40x
2021-03-31	275.20x
2020-12-31	383.71x
2020-09-30	9.79x
2020-06-30	384.62x
2020-03-31	-1103.00x
2019-12-31	156.52x
2019-09-30	224.98x
2019-06-30	312.06x
2019-03-31	221.10x
2018-12-31	230.92x
2018-09-30	76.84x
2018-06-30	209.14x
2018-03-31	-174.31x
2017-12-31	-355.46x
2017-09-30	73.62x
2017-06-30	18.90x
2017-03-31	-22.44x
2016-12-31	4.44x
2016-09-30	2.35x
2016-06-30	4.61x
2016-03-31	3.56x
2015-12-31	6.37x
2015-09-30	-0.01x
2015-06-30	-0.64x
2015-03-31	-0.55x
2014-12-31	-2.05x
2014-09-30	6.10x
2014-06-30	-2.30x
2014-03-31	-2.00x
2013-12-31	-1.81x
2013-09-30	-1.71x
2013-06-30	1.68x
2013-03-31	-0.35x
2012-12-31	2.57x
2012-09-30	-0.88x
2012-06-30	1.33x
2012-03-31	-3.03x
2011-12-31	-3.96x
2011-09-30	-3.82x
2011-06-30	-3.78x
2011-03-31	-1.47x
2010-12-31	3.98x
2010-09-30	-2.10x
2010-06-30	1.31x
2010-03-31	-1.68x
2009-12-31	-3.27x
2009-09-30	-4.83x
2009-06-30	-4.49x
2009-03-31	-5.40x
2008-12-31	-8.04x
2008-09-30	-6.36x
2008-03-31	-5.85x
2007-12-31	-1.22x
2006-12-31	-0.95x
2005-12-31	-2.12x
2005-09-30	-10.97x
2005-03-31	-8.36x
2004-12-31	-9.57x
2003-06-30	-10.77x
2002-12-31	-1.99x

DATE

INTEREST COVERAGE RATIO

2026-06-30

1201.20x

2026-03-31

569.72x

2025-12-31

659.73x

2025-09-30

728.54x

2025-06-30

523.25x

2025-03-31

328.36x

2024-12-31

709.70x

2024-09-30

188.74x

2024-06-30

-727.75x

2024-03-31

213.72x

2023-12-31

232.92x

2023-09-30

344.63x

2023-06-30

295.85x

2023-03-31

52.81x

2022-12-31

105.09x

2022-09-30

215.88x

2022-06-30

375.27x

2022-03-31

171.38x

2021-12-31

147.25x

2021-09-30

536.24x

2021-06-30

393.40x

2021-03-31

275.20x

2020-12-31

383.71x

2020-09-30

9.79x

2020-06-30

384.62x

2020-03-31

-1103.00x

2019-12-31

156.52x

2019-09-30

224.98x

2019-06-30

312.06x

2019-03-31

221.10x

2018-12-31

230.92x

2018-09-30

76.84x

2018-06-30

209.14x

2018-03-31

-174.31x

2017-12-31

-355.46x

2017-09-30

73.62x

2017-06-30

18.90x

2017-03-31

-22.44x

2016-12-31

4.44x

2016-09-30

2.35x

2016-06-30

4.61x

2016-03-31

3.56x

2015-12-31

6.37x

2015-09-30

-0.01x

2015-06-30

-0.64x

2015-03-31

-0.55x

2014-12-31

-2.05x

2014-09-30

6.10x

2014-06-30

-2.30x

2014-03-31

-2.00x

2013-12-31

-1.81x

2013-09-30

-1.71x

2013-06-30

1.68x

2013-03-31

-0.35x

2012-12-31

2.57x

2012-09-30

-0.88x

2012-06-30

1.33x

2012-03-31

-3.03x

2011-12-31

-3.96x

2011-09-30

-3.82x

2011-06-30

-3.78x

2011-03-31

-1.47x

2010-12-31

3.98x

2010-09-30

-2.10x

2010-06-30

1.31x

2010-03-31

-1.68x

2009-12-31

-3.27x

2009-09-30

-4.83x

2009-06-30

-4.49x

2009-03-31

-5.40x

2008-12-31

-8.04x

2008-09-30

-6.36x

2008-03-31

-5.85x

2007-12-31

-1.22x

2006-12-31

-0.95x

2005-12-31

-2.12x

2005-09-30

-10.97x

2005-03-31

-8.36x

2004-12-31

-9.57x

2003-06-30

-10.77x

2002-12-31

-1.99x

Interest Coverage Ratio: 553.04x

INCY Interest Coverage Ratio

INCY Average Interest Coverage Ratio Chart

INCY Current vs Average Interest Coverage Ratio Chart

INCY Interest Coverage Ratio Metrics

INCY Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

INCY Interest Coverage Ratio History

Related Metrics